SCHRODER INVESTMENT MANAGEMENT GROUP
Position in CSTL — Castle Biosciences Inc
CIK 1086619
London, X0
Position in CSTL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,339,001
-$11,806,061 QoQ
Shares Held
298,941
-39.3% QoQ
Ownership
0.986%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $1,268,208,608 across 15 Diagnostics & Research names. CSTL ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,728,440 | $849,580,108 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
188,125 | $105,705,553 | |
| 3 | WAT |
Waters Corp /De/
|
316,203 | $94,165,253 | |
| 4 | DHR |
Danaher Corp /De/
|
313,881 | $59,511,836 | |
| 5 | DGX |
Quest Diagnostics Inc
|
295,035 | $57,820,957 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
31,306 | $39,483,125 | |
| 7 | NEO |
Neogenomics Inc
|
3,568,578 | $26,478,848 | |
| 8 | A |
Agilent Technologies, Inc.
|
65,540 | $7,470,248 |
All Filings in CSTL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,339,001 | 298,941 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,145,062 | 492,161 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,270,011 | 494,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,243,840 | 648,572 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,953,721 | 597,089 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||